Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.


Last Funding Type
Post-IPO Equity
Last Funding Money Raised
Biotechnology,Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 1999
Number Of Employee
5001 - 10000
Operating Status
Stock Symbol
Legal Name
DexCom, Inc.

DexCom, Inc. is a leader in continuous glucose sensing technologies, and focuses 100% on these technologies. Founded in 1999, DexCom’s roots stem from the pioneering 1967 research on implanted glucose sensors at the University of Wisconsin. DexCom started with a focus on creating an implantable Sensor that the body would not reject and that would perform for a long period of time.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
Dexcom has raised a total of $470.08M in funding over 2 rounds. Their latest funding was raised on May 9, 2017 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 9, 2017 Post-IPO Debt $350M Detail
May 2, 2016 Post-IPO Equity $7.22M Detail
Apr 12, 2012 Post-IPO Equity $3.96M Detail
Apr 14, 2005 IPO $56.40M Detail
Jan 6, 2005 Series D $22.50M 4 Detail


Number of Investments
Number of Lead Investments
Dexcom has made 2 investments. Their most recent investment was on Jun 17, 2020, when Current Health raised £3.32M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 17, 2020 Current Health
Series A £3.32M Health Care Yes
Jan 8, 2019 Beta Bionics
Series B $63M Biotechnology


Number of Lead Investors
Number of Investors
Dexcom is funded by 7 investors. Canaan Partners and RWI Group are the most recent investors.
Investor Name Lead Investor Funding Round
Canaan Partners Series D
RWI Group Series D
St. Paul Venture Capital Series D
Warburg Pincus Series D
Federated Kaufmann Fund Series C
Fog City Capital Series C
Windamere Venture Partners Series C

Employee Profiles

Number of Employee Profiles
Dexcom has 17 current employee profiles, including Board member Jonathan Lord
Board member
Board member


Dexcom has had 1 exits. Dexcom most notable exits include Current Health

Date Company Name Exit Type Industry
Oct 12, 2021 Current Health M&A Health Care Detail


Dexcom has acquired 3 organizations. Their most recent acquisition was SweetSpot Diabetes Care on Feb 29, 2012. They acquired SweetSpot Diabetes Care for $8.50M.

Date Company Name
Industry Acquisition Type Price
Analytics $ 8.50M Detail
May 2, 2016 Nintamed
Information Technology acquisition Detail
Cloud Computing acquisition Detail